DeMetsDCaliffR. A historical perspective on clinical trials innovation and leadership: Where have the academics gone?JAMA2012; 305: 713–14.
2.
QuinlanJGaydosBMacaJKramsM. Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development. Clin Trials2010; 7(2): 167–73.
3.
BagiellaEHeitjanDF. Predicting analysis times in randomized clinical trials. Stat Med2001; 20: 2055–63.
4.
YingGSHeitjanDFChenTT. Nonparametric prediction of event times in randomized clinical trials. Clin Trials2004; 1: 352–61.
5.
DonovanJMElliottMRHeitjanDF. Predicting event times in clinical trials when treatment arm is masked. J Biopharm Stat2006; 16: 343–56.
6.
YingGSHeitjanDF. Weibull prediction of event times in clinical trials. Pharm Stat2008; 7: 107–20.
7.
ZhangXLongQ. Joint monitoring and prediction of accrual and event times in clinical trials. Biom J2012; 54: 735–49.
8.
TsiatisAAMehtaCR. On the inefficiency of the adaptive design for monitoring clinical trials. Biometrika2003; 90: 367–78.
